Viewing Study NCT01253551


Ignite Creation Date: 2025-12-24 @ 11:41 PM
Ignite Modification Date: 2025-12-30 @ 2:43 PM
Study NCT ID: NCT01253551
Status: COMPLETED
Last Update Posted: 2012-10-16
First Post: 2010-12-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: VX-950HEP1001 - Drug-drug Interaction Study Between Telaprevir and Raltegravir
Sponsor: Tibotec BVBA
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CR017608
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View